4.2 Editorial Material

Localizing the Seizure Onset Site Through Metabolic Imaging of GABA

Journal

EPILEPSY CURRENTS
Volume 21, Issue 4, Pages 282-284

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/15357597211011988

Keywords

-

Ask authors/readers for more resources

By using ex vivo and in vivo nuclear magnetic resonance spectroscopy (MRS) methods, researchers found that GABA is significantly increased in the epileptogenic zone (EZ) of mesiotemporal lobe epilepsy (MTLE) mouse model, confirming it as the best metabolite to discriminate the EZ. This increase in GABA was specific to the injected hippocampus of mice with MTLE and not reversed by antiepileptic drug exposure.
Objective: Following surgery, focal seizures relapse in 20% to 50% of cases due to the difficulty of delimiting the epileptogenic zone (EZ) by current imaging or electrophysiological techniques. Here, we evaluate an unbiased metabolomics approach based on ex vivo and in vivo nuclear magnetic resonance spectroscopy (MRS) methods to discriminate the EZ in a mouse model of mesiotemporal lobe epilepsy (MTLE). Methods: Four weeks after unilateral injection of kainic acid (KA) into the dorsal hippocampus of mice (KA-MTLE model), we analyzed hippocampal and cortical samples with high-resolution magic angle spinning (HRMAS) MRS. Using advanced multivariate statistics, we identified the metabolites that best discriminate the injected dorsal hippocampus (EZ) and developed an in vivo MEGAPRESS MRS method to focus on the detection of these metabolites in the same mouse model. Results: Multivariate analysis of HRMAS data provided evidence that gamma-aminobutyric acid (GABA) is largely increased in the EZ of KA-MTLE mice and is the metabolite that best discriminates the EZ when compared with sham and, more importantly, when compared with adjacent brain regions. These results were confirmed by capillary electrophoresis analysis and were not reversed by a chronic exposition to an antiepileptic drug (carbamazepine). Then, using in vivo non-invasive GABA-edited MRS, we confirmed that a high GABA increase is specific to the injected hippocampus of KA-MTLE mice. Significance: Our strategy using ex vivo MRS-based untargeted metabolomics to select the most discriminant metabolite(s), followed by in vivo MRS-based targeted metabolomics, is an unbiased approach to accurately define the EZ in a mouse model of focal epilepsy. Results suggest that GABA is a specific biomarker of the EZ in MTLE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available